Back to Search Start Over

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

Authors :
Antoniou, Antonis C.
Kuchenbaecker, Karoline B.
Penny, Soucy
Jonathan, Beesley
Xiaoqing, Chen
Lesley, Mcguffog
Andrew, Lee
Daniel, Barrowdale
Sue, Healey
Sinilnikova, Olga M.
Caligo, Maria A.
Niklas, Loman
Katja, Harbst
Annika, Lindblom
Brita, Arver
Richard, Rosenquist
Per, Karlsson
Kate, Nathanson
Susan, Domchek
Tim, Rebbeck
Anna, Jakubowska
Jan, Lubinski
Katarzyna, Jaworska
Katarzyna, Durda
Zlowocka Perlowska, E.
Elzbieta Złowowcka Perłowska
Ana, Osorio
Mercedes, Duran
Raquel, Andres
Javier, Benitez
Ute, Hamann
Hogervorst, Frans B.
Van, A.
Van Os, Theo A.
Senno, Verhoef
Meijers Heijboer, Hanne E. J.
Juul, Wijnen
Gomez Garcia, Encarna B.
Ligtenberg, Marjolijn J.
Mieke, Kriege
Margriet Collee, J.
Margreet Gem Ausems
Oosterwijk, Jan C.
Susan, Peock
Debra, Frost
Ellis, Steve D.
Radka, Platte
Elena, Fineberg
Gareth Evans, D.
Fiona, Lalloo
Chris, Jacobs
Ros, Eeles
Julian, Adlard
Rosemarie, Davidson
Trevor, Cole
Jackie, Cook
Joan, Paterson
Fiona, Douglas
Carole, Brewer
Shirley, Hodgson
Morrison, Patrick J.
Lisa, Walker
Rogers, Mark T.
Alan, Donaldson
Huw, Dorkins
Godwin, Andrew K.
Betsy, Bove
Dominique Stoppa Lyonnet
Claude, Houdayer
Bruno, Buecher
De Pauw, A.
Antoine Pauw, D. E.
Sylvie, Mazoyer
Alain, Calender
Melanie, Leone
Brigitte Bressac De Paillerets
Olivier, Caron
Hagay, Sobol
Marc, Frenay
Fabienne, Prieur
Sandra, Ferrer
Isabelle, Mortemousque
Saundra, Buys
Mary, Daly
Alexander, Miron
Terry, Mb
Terry, Mu
Mary, Terry
Hopper, John L.
John, Em
Esther, John M.
Melissa, Southey
David, Goldgar
Singer, Christian F.
Anneliese Fink Retter
Muy Kheng Tea
Geschwantler Kaulich, D.
Daphne, Kaulich
Hansen, Thomas V. O.
Nielsen, Finn C.
Barkardottir, Rosa B.
Mia, Gaudet
Tomas, Kirchhoff
Joseph, V.
Joseph, Vijai
Ana Dutra Clarke
Kenneth, Offit
Marion, Piedmonte
Judy, Kirk
David, Cohn
Jean, Hurteau
John, Byron
James, Fiorica
Toland, Amanda E.
Marco, Montagna
Cristina, Oliani
Evgeny, Imyanitov
Claudine, Isaacs
Laima, Tihomirova
Ignacio, Blanco
Conxi, Lazaro
Alex, Teule
Del Valle, J.
Gayther, Simon A.
Kunle, Odunsi
Jenny, Gross
Karlan, Beth Y.
Edith, Olah
Soo Hwang Teo
Ganz, Patricia A.
Beattie, Mary S.
Dorfling, Cecelia M.
Jansen Van Rensburg, E.
Elizabeth Van Rensburg
Orland, Diez
Ava, Kwong
Schmutzler, Rita K.
Barbara, Wappenschmidt
Christoph, Engel
Alfons, Meindl
Nina, Ditsch
Norbert, Arnold
Simone, Heidemann
Dieter, Niederacher
Sabine Preisler Adams
Dorothea, Gadzicki
Raymonda Varon Mateeva
Helmut, Deissler
Andrea, Gehrig
Christian, Sutter
Karin, Kast
Britta, Fiebig
Dieter, Schafer
Trinidad, Caldes
Miguel De La Hoya
Heli, Nevanlinna
Muranen, Taru A.
Bernard, Lesperance
Spurdle, Amanda B.
Neuhausen, Susan L.
Ding, Yuan C.
Xianshu, Wang
Zachary, Fredericksen
Pankratz, Vernon S.
Lindor, Noralane M.
Paolo, Peterlongo
Siranoush, Manoukian
Bernard, Peissel
Daniela, Zaffaroni
Bernardo, Bonanni
Loris, Bernard
Riccardo, Dolcetti
Laura, Papi
Ottini, Laura
Paolo, Radice
Greene, Mark H.
Loud, Jennifer T.
Andrulis, Irene L.
Hilmi, Ozcelik
Anna, Mulligan
Gord, Glendon
Mads, Thomassen
Anne Marie Gerdes
Jensen, Uffe B.
Anne Bine Skytte
Kruse, Torben A.
Georgia Chenevix Trench
Couch, Fergus J.
Jacques, Simard
Easton, Douglas F.
Swedish Breast, Cancer Study S. B.
Facility, Research H.
Study, E.
Collaborators, Study G.
Investigators, K.
Swe Brca Cimba
Embrace, Hebon
Study Gemo Collaborators
Kconfab, Investigators
BMC, Ed.
Collaborative Oncological Gene-environment Study - COGS - - EC:FP7:HEALTH2009-05-01 - 2014-01-31 - 223175 - VALID
Centre for Cancer Genetic Epidemiology
University of Cambridge [UK] (CAM)
Cancer Genomics Laboratory
Centre Hospitalier Universitaire de Québec
Genetics and Population Health Division
Queensland Institute of Medical Research
Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents
Centre Léon Bérard [Lyon]-Hospices Civils de Lyon (HCL)
Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL)
Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL)
Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Section of Genetic Oncology
University of Pisa - Università di Pisa
Department of Oncology
Lund University Hospital
Department of Clinical Genetics
Karolinska University Hospital [Stockholm]
Department of Genetics and Pathology
Uppsala University-Rudbeck Laboratory
Sahlgrenska University Hospital [Gothenburg]
Abramson Cancer Center
University of Pennsylvania-Perelman School of Medicine
University of Pennsylvania
International Hereditary Cancer Centre-Pomeranian Medical University [Szczecin] (PUM)
Postgraduate School of Molecular Medicine
Warsaw Medical University
Human Genetics Group
Spanish National Cancer Research Centre
Biomedical Research Centre Network for Rare Diseases
CIBER de Enfermedades Raras (CIBERER)
Institute of Biology and Molecular Genetics
Universidad de Valladolid [Valladolid] (UVa)
Medical Oncology Division
Hospital Clínico de Zaragoza
Molecular Genetics of Breast Cancer
German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ)
Family Cancer Clinic
Netherlands Cancer Institute
Academic Medical Center - Academisch Medisch Centrum [Amsterdam] (AMC)
University of Amsterdam [Amsterdam] (UvA)-University of Amsterdam [Amsterdam] (UvA)
VU Medical Center
Department of Clinical Genetics and GROM
School for Oncology and Developmental Biology
Department of Human Genetics
Radboud University [Nijmegen]
Erasmus University Medical Center [Rotterdam] (Erasmus MC)-Family Cancer Clinic
Department of Clinical Molecular Genetics
University Medical Center [Utrecht]
Department of Genetics
VU University Medical Center [Amsterdam]
Genetic Medicine
Manchester Academic Health Sciences Centre-Central Manchester University Hospitals
Clinical Genetics
Guy's and St. Thomas' NHS Foundation Trust
Oncogenetics Team
The Institute of Cancer Research-Royal Marsden NHS Foundation Trust
Yorkshire Regional Genetics Service
Ferguson-Smith Centre for Clinical Genetics
Yorkhill Hospitals
West Midlands Regional Genetics Service
Birmingham Women's and Children's NHS Foundation Trust
Sheffield Clinical Genetics Service
Sheffield Children's NHS Foundation Trust
Addenbrookes Hospital
Institute of Human Genetics
Newcastle Upon Tyne Hospitals NHS Foundation Trust
Royal Devon & Exeter Hospital
Medical Genetics Unit
University College of London [London] (UCL)
Northern Ireland Regional Genetics Centre
Belfast Health and Social Care Trust
Department of Medical Genetics
Queen's University [Belfast] (QUB)
Oxford Regional Genetics Service
Churchill Hospital Oxford Centre for Haematology
All Wales Medical Genetics Services
Singleton Hospital
Clinical Genetics Department
St Michael's Hospital
North West Thames Regional Genetics Service
Kennedy-Galton Centre
Department of Pathology and Laboratory Medicine
University of Kansas Medical Center [Kansas City, KS, USA]
Clinical Molecular Genetics Laboratory
Fox Chase Cancer Center
Service de Génétique Oncologique
Institut Curie [Paris]
Unité de génétique et biologie des cancers (U830)
Université Paris Descartes - Paris 5 (UPD5)-Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)
Service de génétique
Institut Gustave Roussy (IGR)
Variabilité Génétique et Maladies Humaines
Institut Universitaire d'Hématologie (IUH)
Université Paris Diderot - Paris 7 (UPD7)-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Consultation de génétique
Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud )
Service d'Oncologie Génétique, de Prévention et Dépistage
Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL)
UNICANCER-Université Côte d'Azur (UCA)
Service de Génétique Clinique Chromosomique et Moléculaire
CHU Saint-Etienne
Laboratoire de Génétique Chromosomique
CH Chambéry
Service de génétique [Tours]
Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Hôpital Bretonneau
Department of Internal Medicine
Huntsman Cancer Institute
Division of Population Science
Department of Cancer Biology
Dana-Farber Cancer Institute [Boston]
Department of Surgery
Harvard Medical School [Boston] (HMS)
Department of Epidemiology
Columbia University [New York]
Centre for Molecular , Environmental, Genetic and Analytic (MEGA) Epidemiology
University of Melbourne-Centre for Molecular, Melbourne School of Population Health
Cancer Prevention Institute of California
entre for Molecular, Environmental, Genetic and Analytic (MEGA) Epidemiology
University of Melbourne
Department of Dermatology
University of Utah School of Medicine [Salt Lake City]
Dept of OB/GYN and Comprehensive Cancer Center
Medizinische Universität Wien = Medical University of Vienna
Center for Genomic Medicine
Copenhagen University Hospital-Rigshospitalet [Copenhagen]
Copenhagen University Hospital
Department of Pathology
University of Iceland [Reykjavik]-Landspitali - University Hospital
Epidemiology Research Program
American Cancer Society
Department of Environmental Medicine
New York University School of Medicine
NYU System (NYU)-NYU System (NYU)-NYU Cancer Institute
Clinical Genetics Service
Memorial Sloane Kettering Cancer Center [New York]
Statistical and Data Center
Roswell Park Cancer Institute [Buffalo]
Australia New Zealand (ANZGOG)
Westmead Hospital [Sydney]
Ohio State University [Columbus] (OSU)
Evanston CCOP - NorthShore University Health System
University of Chicago
Southern Pines Women's Health Center
University of North Carolina [Chapel Hill] (UNC)
University of North Carolina System (UNC)-University of North Carolina System (UNC)
Sarasota Memorial Healthcare
Tufts Medical Center
Department of Molecular Virology, Immunology and Medical Genetics [Colombus]
Ohio State University [Columbus] (OSU)-College of Medicine and Public Health [Colombus]
Immunology and Molecular Oncology Unit
Istituto Oncologico Veneto IOV - IRCCS
U.O.C. di Oncologia
Laboratory of Molecular Oncology
N.N. Petrov Institute of Oncology
Lombardi Comprehensive Cancer Center
Georgetown University [Washington] (GU)
Latvian Biomedical Research and Study Centre [Rīga]
Genetic Counselling Unit
IDIBELL-Catalan Institute of Oncology
Molecular Diagnostic Unit
Department of Preventive Medicine
University of Southern California (USC)-Keck School of Medicine [Los Angeles]
University of Southern California (USC)
Department of Gynecologic Oncology
Women's Cancer Program
Samuel Oschin Comprehensive Cancer Institute
Department of Molecular Genetics
National Institute of Oncology
Cancer Research Initiatives Foundation
Sime Darby Medical Centre-Malaysia and University Malaya Cancer Research Institute-University Malaya Medical Centre
Jonsson Comprehensive Cancer Center at UCLA
Jonsson Comprehensive Cancer Center
UCSF Cancer Risk Program
University of California (UC)
Departments of Medicine, Epidemiology, and Biostatistics
UCSF
Cancer Genetics Laboratory
University of Pretoria [South Africa]
Oncogenetics Laboratory
Vall d'Hebron Institute of Oncology (VHIO)
The Hong Kong Hereditary Breast Cancer Family Registry
The University of Hong Kong (HKU)
Department of Gynaecology and Obstetrics
University Hospital of Cologne [Cologne]-Centre of Familial Breast and Ovarian Cancer-Centre for Integrated Oncology (CIO)
Institute for Medical Informatics, Statistics and Epidemiology [Leipzig] (IMISE)
Universität Leipzig [Leipzig]
Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM)
Ludwig-Maximilians-Universität München (LMU)
University Hospital of Schleswig-Holstein-Christian-Albrechts-Universität zu Kiel (CAU)
University Hospital Düsseldorf-Heinrich Heine Universität Düsseldorf = Heinrich Heine University [Düsseldorf]
Westfälische Wilhelms-Universität Münster = University of Münster (WWU)
Institute of Cell and Molecular Pathology
Hannover Medical School [Hannover] (MHH)
Charité - UniversitätsMedizin = Charité - University Hospital [Berlin]
Universitätsklinikum Ulm - University Hospital of Ulm
Julius-Maximilians-Universität Würzburg (JMU)-Centre of Familial Breast and Ovarian Cancer
Heidelberg University Hospital [Heidelberg]
University Hospital Carl Gustav Carus
Universität Regensburg (UR)
University Hospital Frankfurt a.M.
Molecular Oncology Laboratory
Hospital Clínico San Carlos
Department of Obstetrics and Gynecology
Helsinki University Central Hospital
Hemato-oncology service
Hôpital du Sacré-Coeur de Montréal
Department of Population Sciences
Beckman Research Institute of City of Hope
Department of Laboratory Medicine and Pathology
Mayo Clinic
Unit of Molecular Bases of Genetic Risk and Genetic Testing
Fondazione IRCCS Istituto Nazionale Tumouri (INT)-Fondazione Istituto FIRC di Oncologia Molecolare
Unit of Medical Genetics
Fondazione IRCCS Istituto Nazionale Tumouri (INT)
Division of Cancer Prevention and Genetics
Department of Experimental Oncology
Istituto Europeo di Oncologia-Consortium for Genomics Technology (Cogentech)
Cancer Bioimmunotherapy Unit
IRCCS-Centro di Riferimento Oncologico
Università degli Studi di Firenze = University of Florence (UniFI)
Department of Molecular Medicine
Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome] (UNIROMA)
Clinical Genetics Branch
National Cancer Institute [Bethesda] (NCI-NIH)
National Institutes of Health [Bethesda] (NIH)-National Institutes of Health [Bethesda] (NIH)
Departments of Molecular Genetics and Laboratory Medicine and Pathobiology
University of Toronto-Cancer Care Ontario
Samuel Lunenfeld Research Institute
Mount Sinai Hospital [Toronto, Canada] (MSH)
Department of Laboratory Medicine and Pathobiology
University of Toronto
Department of Laboratory Medicine
St Michael's Hospital-Keenan Research Centre of the Li Ka Shing Knowledge Institute [Toronto]
Ontario Cancer Genetics Network
Cancer Care Ontario
Odense University Hospital
Department of Clinical Genetics [Copenhagen]
Rigshospitalet [Copenhagen]
Copenhagen University Hospital-Copenhagen University Hospital
Skejby Hospital
Department of Laboratory Medicine and Pathology and Health Sciences Research
This work was supported by Cancer Research UK grants C12292/A11174 and C1287/A10118. The research leading to these results has received funding from the European Community's Seventh Framework Programme under grant agreement n° 223175 (HEALTH-F2-2009-223175), from the Canadian Institutes of Health Research for the 'CIHR Team in Familial Risks of Breast Cancer' program and by the Canadian Breast Cancer Research Alliance-grant #019511. This research was also supported by NIH grant CA128978, an NCI Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA116201), a U.S. Department of Defence Ovarian Cancer Idea award (W81XWH-10-1-0341) and grants from the Breast Cancer Research Foundation and the Komen Foundation for the Cure. ACA is a CR-UK Senior Cancer Research Fellow, DFE is CR-UK Principal Research Fellow, GCT is a NHMRC Senior Principal Research Fellow, J.S. is Chairholder of the Canada Research Chair in Oncogenetics
on behalf of CIMBA
SWE-BRCA
HEBON
EMBRACE
GEMO Study Collaborators and kConFab Investigators
European Project: 223175,EC:FP7:HEALTH,FP7-HEALTH-2007-B,COGS(2009)
Pediatric Surgery
Neurology
Medical Oncology
Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E)
Roswell Park Cancer Institute [Buffalo] (RPCI)
Universität Leipzig
Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)
University of Pennsylvania [Philadelphia]-Perelman School of Medicine
University of Pennsylvania [Philadelphia]
Pomeranian Medical University-International Hereditary Cancer Centre
Radboud university [Nijmegen]
University of Kansas Medical Center [Lawrence]
Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5)
Georgetown University
University of California
Westfälische Wilhelms-Universität Münster (WWU)
Julius-Maximilians-Universität Würzburg [Wurtzbourg, Allemagne] (JMU)-Centre of Familial Breast and Ovarian Cancer
Università degli Studi di Firenze = University of Florence [Firenze] (UNIFI)
Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome]
RS: GROW - School for Oncology and Reproduction
Genetica & Celbiologie
Hôpital Bretonneau-Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)
Human Genetics
CCA -Cancer Center Amsterdam
ARD - Amsterdam Reproduction and Development
Human genetics
CCA - Oncogenesis
Source :
Breast Cancer Research; 14(1) (2012), Breast cancer research, 14(1):33. BioMed Central Ltd., Breast Cancer Research, Breast Cancer Research, 2012, 14 (1), pp.R33. ⟨10.1186/bcr3121⟩, Breast Cancer Research : BCR, Antoniou, Antonis C; Kuchenbaecker, Karoline B; Soucy, Penny; Beesley, Jonathan; Chen, Xiaoqing; McGuffog, Lesley; et al.(2012). Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Research, 14(1), R33. doi: http://dx.doi.org/10.1186/bcr3121. Retrieved from: http://www.escholarship.org/uc/item/9n99d8tb, Breast Cancer Research, 14(1), Breast Cancer Research, 14(1). BioMed Central Ltd., Breast Cancer Research; Vol 14, Antoniou, A, Kuchenbaecker, K, Soucy, P, Beesley, J, Chen, X, McGuffog, L, Lee, A, Barrowdale, D, Healey, S, Sinilnikova, O, Caligo, M, Loman, N, Harbst, K, Lindblom, A, Arver, B, Rosenquist, R, Karlsson, P, Nathanson, K, Domchek, S, Rebbeck, T, Jakubowska, A, Lubinski, J, Jaworska, K, Durda, K, Złowowcka-Perłowska, E, Osorio, A, Durán, M, Andrés, R, Benítez, J, Hamann, U, Hogervorst, F, van Os, T, Verhoef, S, Meijers-Heijboer, H, Wijnen, J, Gómez Garcia, E, Ligtenberg, M, Kriege, M, Collée, J M, Ausems, M, Oosterwijk, J, Peock, S, Frost, D, Ellis, S, Platte, R, Fineberg, E, Thomassen, M, Gerdes, A-M, Skytte, A-B, Kruse, T A & CIMBA, SWE-BRCA 2012, ' Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers ', Breast Cancer Research (Online Edition), vol. 14, no. 1, pp. R33 . https://doi.org/10.1186/bcr3121, Breast Cancer Research, BioMed Central, 2012, 14 (1), pp.R33. ⟨10.1186/bcr3121⟩, Breast Cancer Research, 14(1):R33. BioMed Central Ltd, Antoniou, A C, Kuchenbaecker, K B, Soucy, P, Beesley, J, Chen, X Q, McGuffog, L, Lee, A, Barrowdale, D, Healey, S, Sinilnikova, O M, Caligo, M A, Loman, N, Harbst, K, Lindblom, A, Arver, B, Rosenquist, R, Karlsson, P, Nathanson, K, Domchek, S, Rebbeck, T, Jakubowska, A, Lubinski, J, Jaworska, K, Durda, K, Zlowowcka-Perlowska, E, Osorio, A, Duran, M, Andres, R, Benitez, J, Hamann, U, Hogervorst, FB, Os, T A, Verhoef, S, Meijers-Heijboer, E J, van Wijnen, J, Garcia, E B G, Ligtenberg, M J, Kriege, M, Collee, M, Ausems, M G E M, Oosterwijk, J C, Peock, S, Frost, D, Ellis, S D, Platte, R, Fineberg, E, Evans, D G, Lalloo, F, Jacobs, C, Eeles, R, Adlard, J, Davidson, R, Cole, T, Cook, J, Paterson, J, Douglas, F, Brewer, C, Hodgson, S, Morrison, P J, Walker, L, Rogers, M T, Donaldson, A, Dorkins, H, Godwin, A K, Bove, B, Stoppa-Lyonnet, D, Houdayer, C, Buecher, B, de Pauw, A, Mazoyer, S, Calender, A, Leone, M, Bressac-de Paillerets, B, Caron, O, Sobol, H, Frenay, M, Prieur, F, Ferrer, S F, Mortemousque, I, Buys, S, Daly, M, Miron, A, Terry, M B, Hopper, J L, John, E M, Southey, M, Goldgar, D, Singer, C F, Fink-Retter, A, Tea, M K, Kaulich, D G, Hansen, T V O, Nielsen, F C, Barkardottir, R B, Gaudet, M, Kirchhoff, T, Joseph, V, Dutra-Clarke, A & Offit, K 2012, ' Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers ', Breast Cancer Research, vol. 14, no. 1, R33 . https://doi.org/10.1186/bcr3121, Antoniou, AC; Kuchenbaecker, KB; Soucy, P; Beesley, J; Chen, X; McGuffog, L; et al.(2012). Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. BREAST CANCER RESEARCH, 14(1). doi: 10.1186/bcr3121. UCLA: Retrieved from: http://www.escholarship.org/uc/item/4pr3h3nc, Breast cancer research, 14(1). BioMed Central, Breast Cancer Research, 14(1):R33. BioMed Central, Antoniou, A C, Kuchenbaecker, K B, Soucy, P, Beesley, J, Chen, X, McGuffog, L, Lee, A R, Barrowdale, D, Healey, S, Sinilnikova, O M, Caligo, M A, Loman, N, Harbst, K, Lindblom, A, Arver, B, Rosenquist, R, Karlsson, P W, Nathanson, K, Domchek, S, Rebbeck, T, Jakubowska, A, Lubinski, J, Jaworska, K, Durda, K, Złowowcka-Perłowska, E, Osorio, A, Durán, M, Andrés, R, Benítez, J, Hamann, U, Hogervorst, F B, van Os, T A, Verhoef, S, Meijers-Heijboer, H E J, Wijnen, J, Gómez Garcia, E B, Ligtenberg, M J, Kriege, M, Collée, J M, Ausems, M G E M, Oosterwijk, J C, Peock, S, Frost, D, Ellis, S D, Platte, R, Fineberg, E, Evans, D G, Lalloo, F, Jacobs, C, Jensen, U B, Skytte, A-B S & CIMBA, SWE-BRCA 2012, ' Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers ', Breast Cancer Research (Online Edition), vol. 14, no. 1, pp. R33 . https://doi.org/10.1186/bcr3121
Publication Year :
2012
Publisher :
BioMed Central, 2012.

Abstract

INTRODUCTION: Several common alleles have been shown to be associated with breast and/or ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. Recent genome-wide association studies of breast cancer have identified eight additional breast cancer susceptibility loci: rs1011970 (9p21, CDKN2A/B), rs10995190 (ZNF365), rs704010 (ZMIZ1), rs2380205 (10p15), rs614367 (11q13), rs1292011 (12q24), rs10771399 (12p11 near PTHLH) and rs865686 (9q31.2). METHODS: To evaluate whether these single nucleotide polymorphisms (SNPs) are associated with breast cancer risk for BRCA1 and BRCA2 carriers, we genotyped these SNPs in 12,599 BRCA1 and 7,132 BRCA2 mutation carriers and analysed the associations with breast cancer risk within a retrospective likelihood framework. RESULTS: Only SNP rs10771399 near PTHLH was associated with breast cancer risk for BRCA1 mutation carriers (per-allele hazard ratio (HR) = 0.87, 95% CI: 0.81 to 0.94, P-trend = 3 x 10-4). The association was restricted to mutations proven or predicted to lead to absence of protein expression (HR = 0.82, 95% CI: 0.74 to 0.90, P-trend = 3.1 x 10-5, P-difference = 0.03). Four SNPs were associated with the risk of breast cancer for BRCA2 mutation carriers: rs10995190, P-trend = 0.015; rs1011970, P-trend = 0.048; rs865686, 2df-P = 0.007; rs1292011 2df-P = 0.03. rs10771399 (PTHLH) was predominantly associated with estrogen receptor (ER)-negative breast cancer for BRCA1 mutation carriers (HR = 0.81, 95% CI: 0.74 to 0.90, P-trend = 4 x 10-5) and there was marginal evidence of association with ER-negative breast cancer for BRCA2 mutation carriers (HR = 0.78, 95% CI: 0.62 to 1.00, P-trend = 0.049). CONCLUSIONS: The present findings, in combination with previously identified modifiers of risk, will ultimately lead to more accurate risk prediction and an improved understanding of the disease etiology in BRCA1 and BRCA2 mutation carriers.<br />published_or_final_version

Details

Language :
English
ISSN :
14655411 and 1465542X
Database :
OpenAIRE
Journal :
Breast Cancer Research; 14(1) (2012), Breast cancer research, 14(1):33. BioMed Central Ltd., Breast Cancer Research, Breast Cancer Research, 2012, 14 (1), pp.R33. ⟨10.1186/bcr3121⟩, Breast Cancer Research : BCR, Antoniou, Antonis C; Kuchenbaecker, Karoline B; Soucy, Penny; Beesley, Jonathan; Chen, Xiaoqing; McGuffog, Lesley; et al.(2012). Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Research, 14(1), R33. doi: http://dx.doi.org/10.1186/bcr3121. Retrieved from: http://www.escholarship.org/uc/item/9n99d8tb, Breast Cancer Research, 14(1), Breast Cancer Research, 14(1). BioMed Central Ltd., Breast Cancer Research; Vol 14, Antoniou, A, Kuchenbaecker, K, Soucy, P, Beesley, J, Chen, X, McGuffog, L, Lee, A, Barrowdale, D, Healey, S, Sinilnikova, O, Caligo, M, Loman, N, Harbst, K, Lindblom, A, Arver, B, Rosenquist, R, Karlsson, P, Nathanson, K, Domchek, S, Rebbeck, T, Jakubowska, A, Lubinski, J, Jaworska, K, Durda, K, Złowowcka-Perłowska, E, Osorio, A, Durán, M, Andrés, R, Benítez, J, Hamann, U, Hogervorst, F, van Os, T, Verhoef, S, Meijers-Heijboer, H, Wijnen, J, Gómez Garcia, E, Ligtenberg, M, Kriege, M, Collée, J M, Ausems, M, Oosterwijk, J, Peock, S, Frost, D, Ellis, S, Platte, R, Fineberg, E, Thomassen, M, Gerdes, A-M, Skytte, A-B, Kruse, T A & CIMBA, SWE-BRCA 2012, ' Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers ', Breast Cancer Research (Online Edition), vol. 14, no. 1, pp. R33 . https://doi.org/10.1186/bcr3121, Breast Cancer Research, BioMed Central, 2012, 14 (1), pp.R33. ⟨10.1186/bcr3121⟩, Breast Cancer Research, 14(1):R33. BioMed Central Ltd, Antoniou, A C, Kuchenbaecker, K B, Soucy, P, Beesley, J, Chen, X Q, McGuffog, L, Lee, A, Barrowdale, D, Healey, S, Sinilnikova, O M, Caligo, M A, Loman, N, Harbst, K, Lindblom, A, Arver, B, Rosenquist, R, Karlsson, P, Nathanson, K, Domchek, S, Rebbeck, T, Jakubowska, A, Lubinski, J, Jaworska, K, Durda, K, Zlowowcka-Perlowska, E, Osorio, A, Duran, M, Andres, R, Benitez, J, Hamann, U, Hogervorst, FB, Os, T A, Verhoef, S, Meijers-Heijboer, E J, van Wijnen, J, Garcia, E B G, Ligtenberg, M J, Kriege, M, Collee, M, Ausems, M G E M, Oosterwijk, J C, Peock, S, Frost, D, Ellis, S D, Platte, R, Fineberg, E, Evans, D G, Lalloo, F, Jacobs, C, Eeles, R, Adlard, J, Davidson, R, Cole, T, Cook, J, Paterson, J, Douglas, F, Brewer, C, Hodgson, S, Morrison, P J, Walker, L, Rogers, M T, Donaldson, A, Dorkins, H, Godwin, A K, Bove, B, Stoppa-Lyonnet, D, Houdayer, C, Buecher, B, de Pauw, A, Mazoyer, S, Calender, A, Leone, M, Bressac-de Paillerets, B, Caron, O, Sobol, H, Frenay, M, Prieur, F, Ferrer, S F, Mortemousque, I, Buys, S, Daly, M, Miron, A, Terry, M B, Hopper, J L, John, E M, Southey, M, Goldgar, D, Singer, C F, Fink-Retter, A, Tea, M K, Kaulich, D G, Hansen, T V O, Nielsen, F C, Barkardottir, R B, Gaudet, M, Kirchhoff, T, Joseph, V, Dutra-Clarke, A & Offit, K 2012, ' Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers ', Breast Cancer Research, vol. 14, no. 1, R33 . https://doi.org/10.1186/bcr3121, Antoniou, AC; Kuchenbaecker, KB; Soucy, P; Beesley, J; Chen, X; McGuffog, L; et al.(2012). Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. BREAST CANCER RESEARCH, 14(1). doi: 10.1186/bcr3121. UCLA: Retrieved from: http://www.escholarship.org/uc/item/4pr3h3nc, Breast cancer research, 14(1). BioMed Central, Breast Cancer Research, 14(1):R33. BioMed Central, Antoniou, A C, Kuchenbaecker, K B, Soucy, P, Beesley, J, Chen, X, McGuffog, L, Lee, A R, Barrowdale, D, Healey, S, Sinilnikova, O M, Caligo, M A, Loman, N, Harbst, K, Lindblom, A, Arver, B, Rosenquist, R, Karlsson, P W, Nathanson, K, Domchek, S, Rebbeck, T, Jakubowska, A, Lubinski, J, Jaworska, K, Durda, K, Złowowcka-Perłowska, E, Osorio, A, Durán, M, Andrés, R, Benítez, J, Hamann, U, Hogervorst, F B, van Os, T A, Verhoef, S, Meijers-Heijboer, H E J, Wijnen, J, Gómez Garcia, E B, Ligtenberg, M J, Kriege, M, Collée, J M, Ausems, M G E M, Oosterwijk, J C, Peock, S, Frost, D, Ellis, S D, Platte, R, Fineberg, E, Evans, D G, Lalloo, F, Jacobs, C, Jensen, U B, Skytte, A-B S & CIMBA, SWE-BRCA 2012, ' Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers ', Breast Cancer Research (Online Edition), vol. 14, no. 1, pp. R33 . https://doi.org/10.1186/bcr3121
Accession number :
edsair.doi.dedup.....a262a44389663b34550d4aab2a2ab775
Full Text :
https://doi.org/10.1186/bcr3121⟩